H. C. Fehmann

2.5k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

H. C. Fehmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, H. C. Fehmann has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in H. C. Fehmann's work include Diabetes Treatment and Management (28 papers), Pancreatic function and diabetes (23 papers) and Neuropeptides and Animal Physiology (16 papers). H. C. Fehmann is often cited by papers focused on Diabetes Treatment and Management (28 papers), Pancreatic function and diabetes (23 papers) and Neuropeptides and Animal Physiology (16 papers). H. C. Fehmann collaborates with scholars based in Germany, United States and Estonia. H. C. Fehmann's co-authors include Burkhard Göke, Joel F. Habener, Rüdiger Göke, Harald Schmidt, Thomas Linn, Michael Krause, John Eng, R. Arnold, Jens Heyn and P. Berghöfer and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

H. C. Fehmann

43 papers receiving 1.9k citations

Hit Papers

Exendin-4 is a high potency agonist and truncated exendin... 1993 2026 2004 2015 1993 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    1993 695 citations Rüdiger Göke, H. C. Fehmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. C. Fehmann Germany 19 1.3k 1.1k 663 446 303 47 2.0k
A. Kervran France 24 773 0.6× 731 0.7× 464 0.7× 269 0.6× 253 0.8× 64 2.0k
Bo Ahrén Sweden 21 599 0.5× 676 0.6× 428 0.6× 521 1.2× 434 1.4× 32 1.4k
Richard Dobbs United States 23 831 0.6× 1.0k 1.0× 648 1.0× 425 1.0× 197 0.7× 46 1.8k
Carolyn M. Jodka Spain 18 956 0.7× 646 0.6× 506 0.8× 357 0.8× 500 1.7× 22 1.6k
R H Unger United States 15 875 0.7× 1000 1.0× 517 0.8× 162 0.4× 202 0.7× 16 1.7k
Toshio Kaneko Japan 25 552 0.4× 368 0.4× 773 1.2× 464 1.0× 191 0.6× 77 1.8k
Walter S. Zawalich United States 31 1.2k 0.9× 2.0k 1.9× 1.4k 2.1× 249 0.6× 222 0.7× 71 2.8k
J W Ensinck United States 18 639 0.5× 590 0.6× 380 0.6× 220 0.5× 129 0.4× 29 1.2k
Richard Pittner United States 19 487 0.4× 447 0.4× 576 0.9× 350 0.8× 298 1.0× 42 1.5k
Gustaf N. Hendrick United States 14 589 0.4× 522 0.5× 374 0.6× 141 0.3× 82 0.3× 18 1.1k

Countries citing papers authored by H. C. Fehmann

Since Specialization
Citations

This map shows the geographic impact of H. C. Fehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Fehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Fehmann more than expected).

Fields of papers citing papers by H. C. Fehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. C. Fehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Fehmann. The network helps show where H. C. Fehmann may publish in the future.

Co-authorship network of co-authors of H. C. Fehmann

This figure shows the co-authorship network connecting the top 25 collaborators of H. C. Fehmann. A scholar is included among the top collaborators of H. C. Fehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. C. Fehmann. H. C. Fehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fehmann, H. C. & Burkhard Göke. (2009). Amylin, Insel-Amyloid und Diabetes mellitus Typ II. DMW - Deutsche Medizinische Wochenschrift. 115(46). 1769–1772.
2.
Stöckmann, F., et al.. (2009). The Effect of Cyclosporin A on Rat Pancreatic B-Cell: Interaction with the Calcium-Antagonist Diltiazem. Experimental and Clinical Endocrinology & Diabetes. 93(02/03). 213–218.
3.
Printz, H., et al.. (2009). No apparent benefit of liquid formula diet in NIDDM. Experimental and Clinical Endocrinology & Diabetes. 105(3). 134–139. 3 indexed citations
4.
5.
Fehmann, H. C.. (2003). 47-jähriger Mann mit „pure autonomic failure” und Perniziosa. DMW - Deutsche Medizinische Wochenschrift. 128(24). 1347–1350. 1 indexed citations
6.
Fehmann, H. C. & Jens Heyn. (2002). Plasma Resistin Levels in Patients with Type 1 and Type 2 Diabetes Mellitus and in Healthy Controls. Hormone and Metabolic Research. 34(11/12). 671–673. 79 indexed citations
7.
Fehmann, H. C. & B Göke. (1997). The Insulinotropic Gut Hormone Glucagon-Like Peptide-1. 15 indexed citations
8.
Fehmann, H. C., P. Berghöfer, Daniel Brandhorst, et al.. (1997). Leptin inhibition of insulin secretion from isolated human islets. Acta Diabetologica. 34(4). 249–252. 49 indexed citations
9.
Göke, Burkhard & H. C. Fehmann. (1996). Insulin and insulin-like growth factor-I: their role as risk factors in the development of diabetic cardiovascular disease. Diabetes Research and Clinical Practice. 30. S93–S106. 12 indexed citations
10.
Wagner, Ulrich, et al.. (1995). Galanin and somatostatin inhibition of substance P-induced airway mucus secretion in the rat. Neuropeptides. 28(1). 59–64. 19 indexed citations
11.
12.
Wagner, Ulrich, et al.. (1995). Galanin and somatostatin inhibition of neurokinin A and B induced airway mucus secretion in the rat. Life Sciences. 57(3). 283–289. 13 indexed citations
13.
Eissele, R., et al.. (1994). Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study. Cell and Tissue Research. 276(3). 571–580. 9 indexed citations
14.
15.
Göke, Burkhard, Christine Herrmann, Rüdiger Göke, et al.. (1994). Intestinal effects of α‐glucosidase inhibitors: absorption of nutrients and enterohormonal changes. European Journal of Clinical Investigation. 24(S3). 25–30. 40 indexed citations
16.
Lankat–Buttgereit, Brigitte, H. C. Fehmann, Bernhard J. Hering, R. G. Bretzel, & Burkhard Göke. (1994). Expression of the ras-Related rab3a Gene in Human Insulinomas and Normal Human Pancreatic Islets. Pancreas. 9(4). 434–438. 17 indexed citations
17.
Bode, Hans‐Peter, et al.. (1994). Spontaneous Calcium Oscillations in Clonal Endocrine Pancreatic Glucagon-Secreting Cells. Biochemical and Biophysical Research Communications. 205(1). 435–440. 11 indexed citations
18.
Printz, H., Burkhard Göke, H. C. Fehmann, et al.. (1993). Partial Hepatectomy Affects Pancreatic Size and Function in Rats. Pancreas. 8(2). 233–239. 4 indexed citations
19.
Fehmann, H. C. & Joel F. Habener. (1991). Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell line. FEBS Letters. 279(2). 335–340. 69 indexed citations
20.
Fehmann, H. C., et al.. (1990). Atrial natriuretic factor has a weak insulinotropic action in the isolated perfused rat pancreas. Research in Experimental Medicine. 190(1). 253–258. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Kervran Breakdown of academic impact, for papers by Bo Ahrén Breakdown of academic impact, for papers by Richard Dobbs Breakdown of academic impact, for papers by Carolyn M. Jodka Breakdown of academic impact, for papers by R H Unger Breakdown of academic impact, for papers by Toshio Kaneko Breakdown of academic impact, for papers by Walter S. Zawalich Breakdown of academic impact, for papers by J W Ensinck Breakdown of academic impact, for papers by Richard Pittner Breakdown of academic impact, for papers by Gustaf N. Hendrick
Rankless by CCL
2026